Evidence map›Paper›PMID 35204647›Full record

ArticleDiagnostics (Basel, Switzerland)2022

Correction: Ferraz-Amaro et al. SCORE2 Assessment in The Calculation of Cardiovascular Risk in Patients with Rheumatoid Arthritis.

Iván Ferraz-Amaro, Alfonso Corrales, Belén Atienza-Mateo, Nuria Vegas-Revenga, Diana Prieto-Peña, Julio Sánchez-Martín, Cristina Almeida, Juan Carlos Quevedo-Abeledo, Ricardo Blanco, Miguel Á González-Gay

Abstract readPublished Erratum
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Iván Ferraz-AmaroDivision of Rheumatology, Hospital Universitario de Canarias, 38320 Tenerife, Spain.ORCID 0000-0003-0197-5267
Alfonso CorralesDivision of Rheumatology, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, 39008 Santander, Spain.
Belén Atienza-MateoDivision of Rheumatology, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, 39008 Santander, Spain.ORCID 0000-0001-7119-0786
Nuria Vegas-RevengaDivision of Rheumatology, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, 39008 Santander, Spain.
Diana Prieto-PeñaDivision of Rheumatology, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, 39008 Santander, Spain.
Julio Sánchez-MartínDivision of Rheumatology, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, 39008 Santander, Spain.
Cristina AlmeidaDivision of Rheumatology, Hospital Doctor Negrín, 35010 Las Palmas de Gran Canaria, Spain.
Juan Carlos Quevedo-AbeledoDivision of Rheumatology, Hospital Doctor Negrín, 35010 Las Palmas de Gran Canaria, Spain.
Ricardo BlancoDivision of Rheumatology, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, 39008 Santander, Spain.ORCID 0000-0003-2344-2285
Miguel Á González-GayDivision of Rheumatology, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, 39008 Santander, Spain.ORCID 0000-0002-7924-7406

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the original article [...].

Identifiers

PMID35204647
PMCPMC8871168

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.